If you work in law enforcement, or an adjacent industry, you'll know exactly what Axon is. If you've ever binge watched law enforcement body cam footage, you'll have seen the watermark as well.
If you haven't come across Axon Enterprise before, here's the quick version: they make TASER devices, body cameras, and in-car cameras for law enforcement. That hardware is really just the entry point. The real business is the software platform sitting behind it all, think digital evidence management, AI powered tools, cloud storage for footage, and dispatch systems. Once an agency is in, everything talks to everything else.
That last part is key, because it is exactly why Axon has such a powerful network effect. When a police department adopts Axon's body cameras, they almost inevitably end up on the evidence management software. That pulls in prosecutors, courts, and other agencies who need to access and share that evidence. Each new user makes the platform more embedded and harder to leave. Switching costs compound across an entire jurisdiction, it's not one contract, it's dozens of interconnected ones.
So what's with the recent 35% price drop? Most US software-related businesses have experienced fear-based selling on the realisation that AI can now code applications. This presents a very real threat to software-based companies. My take is that this threat is very real, with exceptions. Software with a legislative moat is likely to be safe. Legal, engineering, and medical software generally tends to have a very real barrier to entry for new players due to significant regulatory barriers.
So I don't see the Axon price drop as a business collapse. Annual recurring revenue sits at $1.35 billion with a net revenue retention rate of 125%, meaning existing customers are spending more each year. Future contracted bookings hit $14.4 billion. The issue is more mundane: the stock was priced for perfection, and the market is now demanding proof of execution rather than paying up front for it. Heavy stock-based compensation and a GAAP operating loss in Q4 have added to the noise.
For long term investors, the question isn't whether Axon is broken, it isn't. The question is whether you're comfortable paying a premium for a business that's transitioning from hypergrowth expectations to sustainable ones.
Financial Disclaimer. This content is general in nature and has been prepared without taking into account your personal objectives, financial situation, or needs. It does not constitute financial product advice under the Corporations Act 2001 (Cth). Before acting on any information contained in this post, you should consider whether it is appropriate for your circumstances and, if necessary, seek independent financial advice. References to specific companies, markets, prediction tools, or investment strategies are for informational and educational purposes only and do not constitute a recommendation to buy, hold, or sell any financial product. Past events and probabilistic frameworks discussed are not reliable indicators of future performance.